Join
Live feed
·
PRReleasevia Quantisnow
AN2 Therapeutics Inc. logo

AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK

ByQuantisnow·Wall Street's wire, on your screen.
ANTX· AN2 Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANTX (AN2 Therapeutics Inc.) and more on Quantisnow.